The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
cp2d/as-3 - anticoagulant and additive system
2 marketed package NDCs · 1 active manufacturer
What changed in the last 90 days
Every detected change for cp2d/as-3 - anticoagulant and additive system, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Leukotrap WB System - CP2DAug 20, 2026Mfr exitedGvs Tm Inc · cp2s/as-3 - anticoagulant and additive system
- Leukotrap WB System - CP2DAug 8, 2026Mfr enteredGvs Tm Inc · cp2d/as-3 - anticoagulant and additive system
- Leukotrap WB System - CP2DAug 8, 2026Product updategeneric name: CP2S/AS-3 - Anticoagulant and Additive System → CP2D/AS-3 - Anticoagulant and Additive System
- Leukotrap WB System - CP2DAug 8, 2026Product updategeneric name: CP2S/AS-3 - Anticoagulant and Additive System → CP2D/AS-3 - Anticoagulant and Additive System
Common questions
- Is Cp2d/as-3 - anticoagulant and additive system in shortage right now?
- No. FDA does not currently list Cp2d/as-3 - anticoagulant and additive system in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Cp2d/as-3 - anticoagulant and additive system?
- 1 company has marketed Cp2d/as-3 - anticoagulant and additive system in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.